Internal Medicine, Interventional Cardiology · Mineola, NY
NPI
1306948302
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
120 Mineola Blvd, Suite 500
Mineola, NY, 11501
Phone (516) 663-4480
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
673 services
Medicare patients, 2024
288
Average age 74
Drug cost, 2024
$1.2M
866 prescriptions
Company payments, 2025
$18K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srihari S Naidu was code 99214 (office e&m - established), 410 times for 212 patients. In total Srihari S Naidu billed 673 services in 25 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 410 | 212 | $101.27 | $42K |
| 99215 Office E&M - Established | Office | 87 | 64 | $152.21 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 16 | $68.46 | $2,259 |
| 99291 Critical Care E&M | Facility | 31 | 17 | $175.86 | $5,452 |
| 99205 Office E&M - New | Office | 28 | 28 | $197.32 | $5,525 |
| 93454 Percutaneous Transcatheterization | Facility | 12 | 11 | $205.36 | $2,464 |
| 93460 Percutaneous Transcatheterization | Facility | 11 | 11 | $333.52 | $3,669 |
By year: 2022 $92K for 583 services; 2023 $107K for 780 services; 2024 $85K for 673 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srihari S Naidu prescribed most often to Medicare patients was Camzyos (Mavacamten), with 134 prescriptions and refills. In total Srihari S Naidu wrote 866 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 134 | 134 | 18 | $1.0M |
| Metoprolol Succinate Generic | 114 | 305 | 41 | $2,190 |
| Disopyramide Phosphate Generic | 54 | 124 | 17 | $10K |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 54 | 160 | 27 | $657 |
| Eliquis Apixaban | 50 | 130 | 20 | $73K |
| Hydrochlorothiazide Generic | 49 | 147 | 22 | $140 |
| Rosuvastatin Calcium Generic | 47 | 141 | 23 | $601 |
| Amlodipine Besylate Generic | 38 | 106 | 14 | $198 |
| Furosemide Generic | 34 | 92 | 15 | $321 |
| Atorvastatin Calcium Generic | 33 | 98 | 18 | $243 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 30 | 90 | 15 | $759 |
| Spironolactone Generic | 19 | 45 | Under 11 | $134 |
| Carvedilol Generic | 19 | 57 | Under 11 | $155 |
| Valsartan Generic | 11 | 33 | Under 11 | $503 |
Brand drugs: 226 claims; generic drugs: 640 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srihari S Naidu $18K ($18K in general payments such as food, travel and fees) from 11 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $8,055.
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $8,055 |
| Chiesi USA, Inc. | 2 | $6,048 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $1,738 |
| ZOLL Circulation Inc | 1 | $1,225 |
| Stryker Corporation SYK | 3 | $199 |
| Abiomed JNJ | 1 | $146 |
| Abbott Laboratories ABT | 1 | $110 |
| Biosense Webster, Inc. JNJ | 1 | $62.69 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $51.7 |
| Baxter Healthcare BAX | 1 | $33.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.